期刊文献+

细胞周期抑制性基因ANA在唐氏综合征患者脑组织过量表达

Cell-cycle negative regulatory gene ANA is over-expressed in the brain tissues of patients with Down syndrome
下载PDF
导出
摘要 目的分析唐氏综合征(Down syndrome,DS)胎儿脑组织21号染色体(Chr21)基因的表达,探讨DS脑病变的分子机制。方法采用优化的半定量RT-PCR法,以B2M为内参,检测了7个Chr21基因在DS胎儿及同龄对照胎儿大脑皮层及小脑组织中的表达。结果Chr21基因DYRK1A,SYNJ1,PCP4(purkinje cell protein4gene),C21orf5,C21orf2和C21orf106的表达在DS胎儿大脑皮层及小脑组织较正常对照均没有明显改变。ANA(abundantin neuroepithelium area)基因表达在DS胎儿小脑无明显改变,但在DS胎儿大脑皮层的表达显著升高。结论细胞周期抑制性基因ANA的过表达可能与DS患者脑组织神经元细胞密度低有关。 Objective: To investigate the expression level of genes located in chromosome 21 in the brain tissues of Down syndrome (DS). Methods: An optimized semi-quantitative RT-PCR method was used to evaluate the expression levels of seven genes encoded in chromosome 21 in fetal cortex brain and cerebellum of DS and the control at the end of 20 weeks of gestation. B2M was used as internal reference to normalize cell loss. Results: The expression levels of 6 genes in cortex and cerebellum, including DYRKIA, SYNJI, PCP4, C21orfS, C21orf2 and C21orfl06, were comparable between DS and the control. ANA, a cell-cycle negative regulatory gene, was over-expressed dramatically in the cortex but not in the cerebellum of DS. Conclusion: Over-expression of ANA may contribute to the reduction of neuronal density in DS brain.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2005年第6期608-611,共4页 Journal of Peking University:Health Sciences
基金 国家重点基础研究发展规划项目基金(2001CB510303)资助~~
关键词 唐氏综合征 染色体 21对 基因 逆转录聚合酶链反应 Down syndrome Chromosome, human, pair 21 Genes Reverse transcriptase polymerase chain reaction
  • 相关文献

参考文献21

  • 1Capone GT. Down syndrome: advances in molecular biology and the neurosciences[J]. J Dev Behav Pediatr,2001, 22:40-59.
  • 2Hattori M, Fujiyama A, Taylor TD, et al. The DNA sequence of human chromosome 21[J].Nature, 2000, 405:311-319.
  • 3Marone M, Mozzetti S, De Ritis D, et al. Semiquantitative RT-PCR ANAlysis to assess the expression levels of multiple transcripts from the same sample[J]. Biol Proced Online, 2001, 3:19-25.
  • 4Chen D, Klebe RJ. Controls for validation of relative reverse transcription-polymerase chain reaction assays[J]. PCR Methods and Applications, 1993, 3:127-129.
  • 5Rozen S,Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers[M]. In: Krawetz S, Misener S. Bioinformatics methods and protocols: methods in molecular biology. Totowa, NJ :HumANA Press, 2000. 365-386.
  • 6Ziai MR, Sangameswaran L, Hempstead JL, et al. An immunochemical ANAlysis of the distribution of a brain-specific polypeptide, PEP-19[J]. J Neurochem,1988, 51:1771-1776.
  • 7Utal AK, Stopka AL, Roy M, et al. PEP-19 immunohistochemistry defines the basal ganglia and associated structures in the adult human brain, and is dramatically reduced in Huntington's disease[J]. Neuroscience, 1998, 86:1055-1063.
  • 8Hammerle B, Elizalde C, Galceran J, et al. The MNB/DYRK1A protein kinase: neurobiological functions and Down syndrome implications[J]. J Neural Transm Suppl, 2003, 67:129-137.
  • 9Guimera J, Casas C, Estivill X, et al. Human minibrain homologue (MNBH/DYRK1): characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome[J]. Genomics, 1999, 57:407-418.
  • 10Saito T, Guan F, Papolos DF, et al. Mutation analysis of SYNJ1: a possible candidate gene for chromosome 21q22-linked bipolar disorder[J]. Mol Psychiatry, 2001,6:387-395.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部